Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Axel Leporowski, Brian Godman, Amanj Kurdi, Sean MacBride-Stewart, Margaret Ryan, Simon Hurding, Renata CRM Do Nascimento, Marion Bennie & Alec Morton. (2018) Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications. Expert Review of Pharmacoeconomics & Outcomes Research 18:6, pages 655-666.
Read now
Read now
Vafa Abilova, Amanj Kurdi & Brian Godman. (2018) Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications. Expert Review of Anti-infective Therapy 16:1, pages 77-84.
Read now
Read now
Brian Godman & Joseph Fadare. (2017) Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage. Current Medical Research and Opinion 33:11, pages 2085-2087.
Read now
Read now
Joseph O Fadare, Adekunle O. Adeoti, Olufemi O. Desalu, Okezie O. Enwere, Aliyu M. Makusidi, Olayinka Ogunleye, Taofiki A. Sunmonu, Ilse Truter, Onyinye O Akunne & Brian Godman. (2016) The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Review of Pharmacoeconomics & Outcomes Research 16:5, pages 639-650.
Read now
Read now
L. P. Thai, J. R. Moss, B. Godman & A. I. Vitry. (2016) Cost driver analysis of statin expenditure on Australia’s Pharmaceutical Benefits Scheme. Expert Review of Pharmacoeconomics & Outcomes Research 16:3, pages 419-433.
Read now
Read now
Kristina Garuolienė, Brian Godman, Jolanta Gulbinovič, Krijn Schiffers & Björn Wettermark. (2016) Differences in utilization rates between commercial and administrative databases: implications for future health-economic and cross-national studies. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 149-152.
Read now
Read now
Rohit Kumar, Mohamed Azmi Hassali, Fahad Saleem, Alian A Alrasheedy, Navneet Kaur, Zhi Yen Wong & Muhamad Ali SK Abdul Kader. (2015) Knowledge and perceptions of physicians from private medical centres towards generic medicines: a nationwide survey from Malaysia. Journal of Pharmaceutical Policy and Practice 8:1.
Read now
Read now
Rabiatul Salmi Md Rezal, Mohamed Azmi Hassali, Alian A Alrasheedy, Fahad Saleem, Faridah Aryani Md Yusof & Brian Godman. (2015) Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Review of Anti-infective Therapy 13:5, pages 665-680.
Read now
Read now
Jurij Fürst, Milan Čižman, Jana Mrak, Damjan Kos, Stephen Campbell, Samuel Coenen, Lars L Gustafsson, Luka Fürst & Brian Godman. (2015) The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Review of Anti-infective Therapy 13:2, pages 279-289.
Read now
Read now
Wenjie Zeng, Lars L Gustafsson, Marion Bennie, Alexander E Finlayson & Brian Godman. (2015) Review of ongoing initiatives to improve prescribing efficiency in China; angiotensin receptor blockers as a case history. Expert Review of Pharmacoeconomics & Outcomes Research 15:1, pages 157-169.
Read now
Read now
Brian Godman, Iain Bishop, Alexander E Finlayson, Stephen Campbell, Hye-Young Kwon & Marion Bennie. (2013) Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 469-482.
Read now
Read now
Jessica Fraeyman, Guido Van Hal, Brian Godman & Philippe Beutels. (2013) The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 141-151.
Read now
Read now
Pieter Dylst, Arnold Vulto & Steven Simoens. (2013) Demand-side policies to encourage the use of generic medicines: an overview. Expert Review of Pharmacoeconomics & Outcomes Research 13:1, pages 59-72.
Read now
Read now
Anna Bucsics, Brian Godman, Thomas Burkhardt, Manuela Schmitzer & Rickard E Malmström. (2012) Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 809-819.
Read now
Read now
Vanda Markovic-Pekovic, Ranko Škrbić, Brian Godman & Lars L Gustafsson. (2012) Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:5, pages 661-671.
Read now
Read now
Ljiljana Sovic Brkicic, Brian Godman, Luka Voncina, Slavica Sovic & Maja Relja. (2012) Initiatives to improve prescribing efficiency for drugs to treat Parkinson’s disease in Croatia: influence and future directions. Expert Review of Pharmacoeconomics & Outcomes Research 12:3, pages 373-384.
Read now
Read now
Marion Bennie, Brian Godman, Iain Bishop & Stephen Campbell. (2012) Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland. Expert Review of Pharmacoeconomics & Outcomes Research 12:1, pages 125-130.
Read now
Read now
Mohammed Abuelkhair, Shajahan Abdu, Brian Godman, Sahar Fahmy, Rickard E Malmström & Lars L Gustafsson. (2012) Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi. Expert Review of Pharmacoeconomics & Outcomes Research 12:1, pages 115-124.
Read now
Read now
Articles from other publishers (40)
Georges Hatem, Farah Mcheik, Mathijs Goossens & Sanaa Awada. (2022) Evaluation of the knowledge and perception of the Lebanese physicians toward generics and barriers to their prescription: A cross-sectional survey. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 18:3, pages 168-175.
Crossref
Crossref
Dragan Kalinić, Ranko Škrbić, Duško Vulić, Nataša Stojaković, Svjetlana Stoisavljević-Šatara, Miloš P. Stojiljković, Vanda Marković-Peković, Ana Golić Jelić, Nataša Pilipović-Broćeta, Nathan D. Wong & Brian Godman. (2022) Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up. Frontiers in Pharmacology 13.
Crossref
Crossref
Magdalena Zielińska & Tomasz Hermanowski. (2022) Sources of Information on Medicinal Products Among Physicians – A Survey Conducted Among Primary Care Physicians in Poland. Frontiers in Pharmacology 12.
Crossref
Crossref
RajeshB Hadia, DhavalB Joshi, KushalH Gohel & Nikhil Khambhati. (2022) Knowledge, attitude, and practice of generic medicines among physicians at multispecialty hospital: An observational study. Perspectives in Clinical Research 13:3, pages 155.
Crossref
Crossref
Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell & Bjorn Wettermark. (2021) Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications. BioMed Research International 2021, pages 1-16.
Crossref
Crossref
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Crossref
Brian Godman, Mainul Haque, Trudy Leong, Eleonora Allocati, Santosh Kumar, Salequl Islam, Jaykaran Charan, Farhana Akter, Amanj Kurdi, Carlos Vassalo, Muhammed Abu Bakar, Sagir Abdur Rahim, Nusrat Sultana, Farzana Deeba, M. A. Halim Khan, A. B. M. Muksudul Alam, Iffat Jahan, Zubair Mahmood Kamal, Humaira Hasin, Munzur-E-Murshid, Shamsun Nahar, Monami Haque, Siddhartha Dutta, Jha Pallavi Abhayanand, Rimple Jeet Kaur, Godfrey Mutashambara Rwegerera, Renata Cristina Rezende Macedo do Nascimento, Isabella Piassi Dias Godói, Mohammed Irfan, Adefolarin A. Amu, Patrick Matowa, Joseph Acolatse, Robert Incoom, Israel Abebrese Sefah, Jitendra Acharya, Sylvia Opanga, Lisper Wangeci Njeri, David Kimonge, Hye-Young Kwon, SeungJin Bae, Karen Koh Pek Khuan, Abdullahi Rabiu Abubakar, Ibrahim Haruna Sani, Tanveer Ahmed Khan, Shahzad Hussain, Zikria Saleem, Oliver Ombeva Malande, Thereza Piloya-Were, Rosana Gambogi, Carla Hernandez Ortiz, Luke Alutuli, Aubrey Chichonyi Kalungia, Iris Hoxha, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Ott Laius, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuoliene, Jolanta Gulbinovič, Magdalene Wladysiuk, Jakub Rutkowski, Ileana Mardare, Jurij Fürst, Stuart McTaggart, Sean MacBride-Stewart, Caridad Pontes, Corinne Zara, Eunice Twumwaa Tagoe, Rita Banzi, Janney Wale & Mihajlo Jakovljevic. (2021) The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future. Frontiers in Public Health 9.
Crossref
Crossref
Lei Chen, Ying Yang, Mi Luo, Borui Hu, Shicheng Yin & Zongfu Mao. (2020) The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China. International Journal of Environmental Research and Public Health 17:24, pages 9415.
Crossref
Crossref
Amanj Kurdi, Rachel Ann Elliott & Li-Chia Chen. (2020) Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework. BMJ Open 10:6, pages e035910.
Crossref
Crossref
Mohamed Gad, Ahmed Salem, Wija Oortwijn, Ruaraidh Hill & Brian Godman. (2020) Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions. Frontiers in Pharmacology 11.
Crossref
Crossref
Amanj I.B. Kurdi, Rachel A. Elliott & Li-Chia Chen. (2019) Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors. Journal of Hypertension 37:6, pages 1285-1293.
Crossref
Crossref
Hye-Young Kwon, Seungjin Bae, Sang-eun Choi, Sylvia Park, Eui-Kyung Lee, Sungmin Park & Jinhyun Kim. (2019) Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea. Health Policy 123:4, pages 388-392.
Crossref
Crossref
Arianit Jakupi, Brian Godman, Antony Martin, Alan Haycox & Indrit Baholli. (2018) Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications. PharmacoEconomics - Open 2:4, pages 423-432.
Crossref
Crossref
Ljubica Bojanić, Vanda Marković-Peković, Ranko Škrbić, Nataša Stojaković, Mirjana Ðermanović, Janja Bojanić, Jurij Fürst, Amanj B. Kurdi & Brian Godman. (2018) Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications. Frontiers in Pharmacology 9.
Crossref
Crossref
Tomasz Bochenek, Vafa Abilova, Ali Alkan, Bogdan Asanin, Iñigo de Miguel Beriain, Zeljka Besovic, Patricia Vella Bonanno, Anna Bucsics, Michal Davidescu, Elfi De Weerdt, Natasa Duborija-Kovacevic, Jurij Fürst, Mina Gaga, Elma Gailīte, Jolanta Gulbinovič, Emre U. Gürpınar, Balázs Hankó, Vincent Hargaden, Tor A. Hotvedt, Iris Hoxha, Isabelle Huys, Andras Inotai, Arianit Jakupi, Helena Jenzer, Roberta Joppi, Ott Laius, Marie-Camille Lenormand, Despina Makridaki, Admir Malaj, Kertu Margus, Vanda Marković-Peković, Nenad Miljković, João L. de Miranda, Stanislav Primožič, Dragana Rajinac, David G. Schwartz, Robin Šebesta, Steven Simoens, Juraj Slaby, Ljiljana Sović-Brkičić, Tomas Tesar, Leonidas Tzimis, Ewa Warmińska & Brian Godman. (2018) Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries. Frontiers in Pharmacology 8.
Crossref
Crossref
Winnie de Bruijn, Cristina Ibáñez, Pia Frisk, Hanne Bak Pedersen, Ali Alkan, Patricia Vella Bonanno, Ljiljana S. Brkičić, Anna Bucsics, Guillaume Dedet, Jaran Eriksen, Joseph O. Fadare, Jurij Fürst, Gisselle Gallego, Isabella P. Godói, Augusto A. Guerra Júnior, Hakkı Gürsöz, Saira Jan, Jan Jones, Roberta Joppi, Saim Kerman, Ott Laius, Newman Madzikwa, Einar Magnússon, Mojca Maticic, Vanda Markovic-Pekovic, Amos Massele, Olayinka Ogunleye, Aisling O'Leary, Jutta Piessnegger, Catherine Sermet, Steven Simoens, Celda Tiroyakgosi, Ilse Truter, Magnus Thyberg, Kristina Tomekova, Magdalena Wladysiuk, Sotiris Vandoros, Elif H. Vural, Corinne Zara & Brian Godman. (2016) Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future. Frontiers in Pharmacology 7.
Crossref
Crossref
Elisabetta Poluzzi, Giacomo Veronese, Carlo Piccinni, Emanuel Raschi, Ariola Koci, Paola Pagano, Brian Godman, Giulio Marchesini, Giuseppe Boriani & Fabrizio De Ponti. (2016) Switching among Equivalents in Chronic Cardiovascular Therapies: ‘Real World’ Data from Italy. Basic & Clinical Pharmacology & Toxicology 118:1, pages 63-69.
Crossref
Crossref
Wenjie Zeng, Alexander E Finlayson, Sushma Shankar, Winnie de Bruyn & Brian Godman. (2015) Prescribing efficiency of proton pump inhibitors in China: influence and future directions. BMC Health Services Research 15:1.
Crossref
Crossref
Amanj Baker, Li-Chia Chen, Rachel A. Elliott & Brian Godman. (2015) The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design. BMC Health Services Research 15:1.
Crossref
Crossref
Hye-Young Kwon, Bongmin Yang & Brian Godman. (2015) Key Components of Increased Drug Expenditure in South Korea: Implications for the Future. Value in Health Regional Issues 6, pages 14-21.
Crossref
Crossref
Ilse Truter, Sushma Shankar, Marion Bennie, Menno van Woerkom & Brian Godman. (2015) Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors: findings and implications. Journal of Comparative Effectiveness Research 4:2, pages 123-131.
Crossref
Crossref
Brian Godman, Max Petzold, Kathleen Bennett, Marion Bennie, Anna Bucsics, Alexander E Finlayson, Andrew Martin, Marie Persson, Jutta Piessnegger, Emanuel Raschi, Steven Simoens, Corinne Zara & Corrado Barbui. (2014) Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications. BMC Medicine 12:1.
Crossref
Crossref
Marina Polić-Vižintin, Danijela Štimac, Zvonimir Šostar & Ingrid Tripković. (2014) Distribution and trends in outpatient utilization of generic versusbrand name psychopharmaceuticals during a ten-year period in Croatia. BMC Health Services Research 14:1.
Crossref
Crossref
James C. Moon, Brian Godman, Max Petzold, Samantha Alvarez-Madrazo, Kathleen Bennett, Iain Bishop, Anna Bucsics, Ulrik Hesse, Andrew Martin, Steven Simoens, Corinne Zara & Rickard E. Malmström. (2014) Different initiatives across Europe to enhance losartan utilization post generics: impact and implications. Frontiers in Pharmacology 5.
Crossref
Crossref
Wenjie Zeng, Junjie Zhen, Mengying Feng, Stephen M Campbell, Alexander E Finlayson & Brian Godman. (2014) Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction. Journal of Comparative Effectiveness Research 3:4, pages 371-386.
Crossref
Crossref
Sabine Vogler, Christine Leopold, Nina Zimmermann, Claudia Habl & Kees de Joncheere. (2014) The Pharmaceutical Pricing and Reimbursement Information (PPRI) initiative—Experiences from engaging with pharmaceutical policy makers. Health Policy and Technology 3:2, pages 139-148.
Crossref
Crossref
Andrew Martin, Brian GodmanJamilette Miranda, Jeanette Tilstone, Nigget Saleem, Erika Olsson, Angela Acosta, Luis Restrepo & Marion Bennie. (2014) Measures to improve angiotensin receptor blocker prescribing efficiency in the UK: findings and implications. Journal of Comparative Effectiveness Research 3:1, pages 41-51.
Crossref
Crossref
Ulrik Hesse, Brian Godman, Max Petzold, Andrew Martin & Rickard E. Malmström. (2013) Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries. Applied Health Economics and Health Policy 11:6, pages 677-685.
Crossref
Crossref
Brian Godman, Kristien De Bruyn, Jamilette Miranda, Emanuel Raschi, Marion Bennie, Corrado Barbui & Steven Simoens. (2013) Generic atypical antipsychotic drugs in Belgium: their influence and implications. Journal of Comparative Effectiveness Research 2:6, pages 551-561.
Crossref
Crossref
Hye-Young Kwon, Ji-Min Hong, Brian Godman & Bong-Min Yang. (2013) Price cuts and drug spending in South Korea: The case of antihyperlipidemic agents. Health Policy 112:3, pages 217-226.
Crossref
Crossref
Pieter Dylst, Arnold Vulto, Brian Godman & Steven Simoens. (2013) Generic Medicines: Solutions for a Sustainable Drug Market?. Applied Health Economics and Health Policy 11:5, pages 437-443.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Corrado Barbui, Marion Bennie, Alexander E Finlayson, Emanuel Raschi & Bjorn Wettermark. (2013) Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications. Journal of Pharmaceutical Health Services Research 4:3, pages 139-150.
Crossref
Crossref
Steven Simoens, Kristien De Bruyn, Jamilette Miranda, Marion Bennie, Rickard E. Malmström & Brian Godman. (2013) Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future. Journal of Pharmaceutical Health Services Research 4:3, pages 173-181.
Crossref
Crossref
B. Godman, B. Wettermark, J. Miranda, M. Bennie, A. Martin & R. E. Malmström. (2013) Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries. International Journal of Clinical Practice 67:9, pages 853-862.
Crossref
Crossref
Brian Godman, Marie Persson, Jamilette Miranda, Peter Skiöld, Björn Wettermark, Corrado Barbui & Lars L. Gustafsson. (2013) Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden. Applied Health Economics and Health Policy 11:4, pages 383-393.
Crossref
Crossref
Sylvain Pichetti, Catherine Sermet, Brian Godman, Stephen M. Campbell & Lars L. Gustafsson. (2013) Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France. Applied Health Economics and Health Policy 11:3, pages 205-218.
Crossref
Crossref
M. Bennie, I. Bishop, B. Godman, C. Barbui, E. Raschi, S. Campbell, J. Miranda & L. L. Gustafsson. (2013) Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications. International Journal of Clinical Practice 67:2, pages 170-180.
Crossref
Crossref
Brian Godman & Lars L. Gustafsson. (2013) A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing. Applied Health Economics and Health Policy 11:1, pages 79-82.
Crossref
Crossref
Marija KalabaBrian Godman, Aleksandar Vuksanović, Marion Bennie & Richard E Malmström. (2012) Possible ways to enhance renin–angiotensin prescribing efficiency: Republic of Serbia as a case history?. Journal of Comparative Effectiveness Research 1:6, pages 539-549.
Crossref
Crossref
Menno van Woerkom, Hans Piepenbrink, Brian GodmanJoost de Metz, Stephen Campbell, Marion Bennie, Marietta Eimers & Lars L Gustafsson. (2012) Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications. Journal of Comparative Effectiveness Research 1:6, pages 527-538.
Crossref
Crossref